Aktienanalyse zu Iris Acquisition II Corp (IRAB)

KI-Analyse of Iris Acquisition II Corp (IRAB)

Halten

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Iris Acquisition II Corp (IRAB) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E

Aktuelles P/E

0.00

Erwartetes EV/EBITDA

5J-Durchschnitt EV/EBITDA

Aktuelles EV/EBITDA

0.00

Erwartetes KUV

5J-Durchschnitt P/S

Aktuelles P/S

0.00

Whales, die IRAB halten

C

Cable Car Capital LLC

+ HältIRAB

-4.58%

3-Monats-Rendite

A

Aristeia Capital, LLC

+ HältIRAB

-5.59%

3-Monats-Rendite

IRAB FAQ – beantwortet von Alphio AI

Iris Acquisition Corp II, located in Dubai, the United Arab Emirates, is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It operates in the Financials sector.

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.